Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 79 | 2023 | 964 | 6.450 |
Why?
|
Coronary Circulation | 71 | 2021 | 1572 | 5.910 |
Why?
|
Myocardium | 63 | 2023 | 4772 | 5.240 |
Why?
|
Myocardial Perfusion Imaging | 30 | 2023 | 554 | 4.730 |
Why?
|
Ventricular Remodeling | 34 | 2021 | 1223 | 3.510 |
Why?
|
Gadolinium DTPA | 41 | 2019 | 836 | 2.940 |
Why?
|
Contrast Media | 73 | 2023 | 5300 | 2.820 |
Why?
|
Magnetic Resonance Imaging | 129 | 2023 | 35425 | 2.740 |
Why?
|
Cardiomyopathies | 19 | 2023 | 1912 | 2.120 |
Why?
|
Ventricular Function, Left | 53 | 2024 | 3666 | 2.030 |
Why?
|
Heart | 24 | 2023 | 4464 | 1.940 |
Why?
|
Heart Diseases | 14 | 2023 | 2789 | 1.890 |
Why?
|
Fractional Flow Reserve, Myocardial | 9 | 2022 | 289 | 1.830 |
Why?
|
Gadolinium | 22 | 2023 | 952 | 1.750 |
Why?
|
Magnetic Resonance Angiography | 24 | 2017 | 1443 | 1.600 |
Why?
|
Fibrosis | 33 | 2023 | 2029 | 1.550 |
Why?
|
Myocardial Ischemia | 26 | 2023 | 2148 | 1.540 |
Why?
|
Coronary Artery Disease | 29 | 2023 | 6486 | 1.340 |
Why?
|
Stroke Volume | 46 | 2024 | 5006 | 1.300 |
Why?
|
Heart Ventricles | 23 | 2021 | 3817 | 1.220 |
Why?
|
Hyperemia | 10 | 2013 | 225 | 1.120 |
Why?
|
Hypertrophy, Left Ventricular | 10 | 2021 | 857 | 1.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 14 | 2022 | 1265 | 1.100 |
Why?
|
Predictive Value of Tests | 61 | 2023 | 15078 | 1.080 |
Why?
|
Cardiovascular System | 2 | 2023 | 831 | 1.050 |
Why?
|
Image Enhancement | 25 | 2021 | 2921 | 0.970 |
Why?
|
Myocardial Infarction | 24 | 2024 | 11718 | 0.870 |
Why?
|
Cardiac Imaging Techniques | 6 | 2021 | 269 | 0.840 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2019 | 851 | 0.830 |
Why?
|
Anthracyclines | 4 | 2023 | 288 | 0.830 |
Why?
|
Coronary Stenosis | 10 | 2016 | 834 | 0.800 |
Why?
|
Image Interpretation, Computer-Assisted | 18 | 2019 | 3326 | 0.770 |
Why?
|
Ventricular Dysfunction, Left | 15 | 2019 | 2073 | 0.760 |
Why?
|
Myocytes, Cardiac | 6 | 2018 | 1629 | 0.750 |
Why?
|
Transposition of Great Vessels | 4 | 2018 | 588 | 0.750 |
Why?
|
Aorta, Thoracic | 8 | 2016 | 1084 | 0.710 |
Why?
|
Atherosclerosis | 18 | 2024 | 3444 | 0.710 |
Why?
|
Coronary Angiography | 24 | 2020 | 4576 | 0.700 |
Why?
|
Ventricular Dysfunction | 4 | 2021 | 143 | 0.690 |
Why?
|
Magnetic Resonance Spectroscopy | 13 | 2023 | 3759 | 0.680 |
Why?
|
Heart Failure | 16 | 2024 | 10895 | 0.680 |
Why?
|
Spironolactone | 3 | 2023 | 382 | 0.660 |
Why?
|
Amyloidosis | 5 | 2021 | 796 | 0.650 |
Why?
|
Perfusion | 9 | 2023 | 1360 | 0.630 |
Why?
|
Myocarditis | 6 | 2022 | 771 | 0.620 |
Why?
|
Myocardial Contraction | 11 | 2014 | 1579 | 0.620 |
Why?
|
Aortic Valve Stenosis | 10 | 2023 | 1965 | 0.620 |
Why?
|
Microcirculation | 9 | 2021 | 1287 | 0.620 |
Why?
|
Echocardiography, Doppler | 8 | 2021 | 935 | 0.610 |
Why?
|
Tetralogy of Fallot | 4 | 2019 | 623 | 0.600 |
Why?
|
Exercise Test | 15 | 2019 | 2073 | 0.580 |
Why?
|
Coronary Disease | 18 | 2009 | 6077 | 0.580 |
Why?
|
Humans | 250 | 2024 | 744366 | 0.580 |
Why?
|
Coronary Vessels | 11 | 2018 | 3107 | 0.550 |
Why?
|
Image Processing, Computer-Assisted | 28 | 2021 | 8949 | 0.550 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2018 | 581 | 0.540 |
Why?
|
Atrial Function, Left | 6 | 2018 | 173 | 0.530 |
Why?
|
Vasodilator Agents | 9 | 2014 | 976 | 0.520 |
Why?
|
Extracellular Matrix | 5 | 2017 | 1741 | 0.520 |
Why?
|
Organometallic Compounds | 11 | 2019 | 665 | 0.520 |
Why?
|
Regional Blood Flow | 12 | 2019 | 1525 | 0.510 |
Why?
|
Cardiomegaly | 2 | 2016 | 620 | 0.500 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2024 | 164 | 0.500 |
Why?
|
Body Water | 2 | 2013 | 343 | 0.500 |
Why?
|
Microspheres | 7 | 2012 | 777 | 0.490 |
Why?
|
Male | 160 | 2024 | 350115 | 0.480 |
Why?
|
Middle Aged | 125 | 2024 | 213390 | 0.480 |
Why?
|
Pericardium | 5 | 2018 | 667 | 0.470 |
Why?
|
Artificial Intelligence | 5 | 2022 | 2213 | 0.470 |
Why?
|
Adenosine | 8 | 2015 | 825 | 0.470 |
Why?
|
Microvascular Angina | 4 | 2018 | 15 | 0.460 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2024 | 1344 | 0.460 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1273 | 0.450 |
Why?
|
Female | 156 | 2024 | 380193 | 0.450 |
Why?
|
Amyloid | 2 | 2018 | 795 | 0.440 |
Why?
|
Immunoglobulin Light Chains | 1 | 2014 | 277 | 0.440 |
Why?
|
Endomyocardial Fibrosis | 1 | 2012 | 41 | 0.440 |
Why?
|
Prognosis | 40 | 2024 | 29060 | 0.430 |
Why?
|
Ventricular Fibrillation | 1 | 2015 | 538 | 0.430 |
Why?
|
Prealbumin | 1 | 2014 | 210 | 0.420 |
Why?
|
Ventriculography, First-Pass | 4 | 2013 | 20 | 0.420 |
Why?
|
Atrial Fibrillation | 11 | 2024 | 5035 | 0.420 |
Why?
|
Hypoplastic Left Heart Syndrome | 5 | 2021 | 573 | 0.420 |
Why?
|
Heart Atria | 7 | 2021 | 1356 | 0.410 |
Why?
|
Sensitivity and Specificity | 30 | 2014 | 14723 | 0.410 |
Why?
|
Aged | 96 | 2023 | 163288 | 0.400 |
Why?
|
Models, Cardiovascular | 9 | 2009 | 996 | 0.400 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2014 | 138 | 0.390 |
Why?
|
Blood Flow Velocity | 8 | 2019 | 1423 | 0.390 |
Why?
|
Collateral Circulation | 4 | 2007 | 287 | 0.380 |
Why?
|
Sarcomeres | 3 | 2021 | 374 | 0.380 |
Why?
|
Reproducibility of Results | 27 | 2022 | 19905 | 0.380 |
Why?
|
Oxygen Consumption | 7 | 2019 | 1868 | 0.380 |
Why?
|
Iron | 2 | 2015 | 1774 | 0.370 |
Why?
|
Tissue Survival | 3 | 2008 | 118 | 0.370 |
Why?
|
Prospective Studies | 45 | 2024 | 53290 | 0.360 |
Why?
|
Ventricular Function, Right | 7 | 2019 | 591 | 0.360 |
Why?
|
Coronary Artery Bypass | 3 | 2022 | 2288 | 0.360 |
Why?
|
Imaging, Three-Dimensional | 10 | 2016 | 4042 | 0.360 |
Why?
|
Capillary Permeability | 2 | 2014 | 798 | 0.350 |
Why?
|
Edema | 1 | 2014 | 789 | 0.350 |
Why?
|
Tomography, X-Ray Computed | 17 | 2019 | 20130 | 0.340 |
Why?
|
Death, Sudden, Cardiac | 6 | 2023 | 1541 | 0.330 |
Why?
|
Hypertension | 7 | 2016 | 8479 | 0.320 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 105 | 0.320 |
Why?
|
Swine | 17 | 2014 | 5918 | 0.320 |
Why?
|
Aorta | 5 | 2020 | 2062 | 0.320 |
Why?
|
Systole | 11 | 2016 | 958 | 0.320 |
Why?
|
Myocardial Reperfusion | 4 | 2021 | 351 | 0.320 |
Why?
|
Exercise Tolerance | 5 | 2023 | 768 | 0.320 |
Why?
|
Heart Defects, Congenital | 10 | 2019 | 4583 | 0.310 |
Why?
|
Tomography | 2 | 2019 | 390 | 0.310 |
Why?
|
Cardiac Surgical Procedures | 4 | 2016 | 3537 | 0.310 |
Why?
|
Obesity | 6 | 2016 | 12746 | 0.300 |
Why?
|
Adult | 72 | 2024 | 214052 | 0.290 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2023 | 692 | 0.290 |
Why?
|
Retinal Artery | 1 | 2007 | 111 | 0.290 |
Why?
|
Microvessels | 3 | 2018 | 544 | 0.290 |
Why?
|
Meglumine | 5 | 2019 | 149 | 0.290 |
Why?
|
Linear Models | 16 | 2017 | 5953 | 0.290 |
Why?
|
Electrocardiography | 15 | 2017 | 6442 | 0.290 |
Why?
|
Sports | 2 | 2022 | 688 | 0.280 |
Why?
|
Pulmonary Veins | 4 | 2014 | 761 | 0.270 |
Why?
|
Time Factors | 30 | 2019 | 40075 | 0.270 |
Why?
|
Fatty Liver | 3 | 2017 | 727 | 0.260 |
Why?
|
Risk Factors | 40 | 2023 | 72296 | 0.260 |
Why?
|
Insulin Resistance | 3 | 2019 | 3864 | 0.250 |
Why?
|
Arrhythmias, Cardiac | 7 | 2023 | 2269 | 0.250 |
Why?
|
Reference Values | 12 | 2020 | 4982 | 0.250 |
Why?
|
Embolism, Air | 1 | 2004 | 111 | 0.240 |
Why?
|
Myocardial Revascularization | 4 | 2005 | 841 | 0.240 |
Why?
|
Cardiac Output, Low | 1 | 2004 | 195 | 0.240 |
Why?
|
Case-Control Studies | 20 | 2021 | 21748 | 0.230 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2014 | 254 | 0.230 |
Why?
|
Heart Transplantation | 5 | 2016 | 3112 | 0.230 |
Why?
|
Aging | 4 | 2020 | 8664 | 0.220 |
Why?
|
Adiposity | 4 | 2017 | 1806 | 0.220 |
Why?
|
Weight Loss | 1 | 2014 | 2625 | 0.220 |
Why?
|
Ethylene Glycols | 2 | 2020 | 156 | 0.210 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39052 | 0.210 |
Why?
|
Disease Models, Animal | 10 | 2016 | 18034 | 0.210 |
Why?
|
Catheter Ablation | 6 | 2021 | 2758 | 0.210 |
Why?
|
Arteritis | 1 | 2024 | 159 | 0.200 |
Why?
|
Age Factors | 12 | 2020 | 18373 | 0.200 |
Why?
|
Cardiovascular Diseases | 13 | 2021 | 15160 | 0.200 |
Why?
|
Algorithms | 9 | 2014 | 13882 | 0.200 |
Why?
|
Radiographic Image Enhancement | 3 | 2007 | 885 | 0.200 |
Why?
|
Echocardiography | 15 | 2020 | 5099 | 0.190 |
Why?
|
Doxorubicin | 2 | 2018 | 2234 | 0.190 |
Why?
|
Edema, Cardiac | 2 | 2017 | 18 | 0.190 |
Why?
|
Extracellular Space | 3 | 2013 | 595 | 0.190 |
Why?
|
Friedreich Ataxia | 1 | 2021 | 76 | 0.190 |
Why?
|
Cicatrix | 3 | 2022 | 764 | 0.190 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2010 | 1107 | 0.180 |
Why?
|
Risk Assessment | 16 | 2019 | 23336 | 0.180 |
Why?
|
Young Adult | 22 | 2023 | 56429 | 0.180 |
Why?
|
Diastole | 6 | 2014 | 791 | 0.180 |
Why?
|
Benzylamines | 1 | 2020 | 223 | 0.180 |
Why?
|
Collagen | 2 | 2013 | 2688 | 0.180 |
Why?
|
Uracil | 1 | 2020 | 165 | 0.170 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 102 | 0.170 |
Why?
|
Adipose Tissue | 3 | 2017 | 3280 | 0.170 |
Why?
|
Molecular Imaging | 2 | 2023 | 828 | 0.170 |
Why?
|
HIV Infections | 5 | 2024 | 16715 | 0.170 |
Why?
|
Animals | 34 | 2020 | 168768 | 0.170 |
Why?
|
Pulmonary Artery | 3 | 2017 | 1912 | 0.170 |
Why?
|
Positron-Emission Tomography | 5 | 2019 | 6234 | 0.160 |
Why?
|
Artifacts | 5 | 2010 | 1904 | 0.160 |
Why?
|
Elasticity | 5 | 2015 | 657 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2004 | 1620 | 0.160 |
Why?
|
Aniline Compounds | 2 | 2020 | 986 | 0.160 |
Why?
|
Severity of Illness Index | 15 | 2020 | 15535 | 0.160 |
Why?
|
Cardiovascular Agents | 2 | 2023 | 850 | 0.160 |
Why?
|
Intra-Abdominal Fat | 4 | 2015 | 591 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2021 | 11726 | 0.150 |
Why?
|
Treatment Outcome | 20 | 2024 | 63107 | 0.150 |
Why?
|
Cardiac Volume | 3 | 2013 | 210 | 0.150 |
Why?
|
American Heart Association | 3 | 2022 | 1057 | 0.150 |
Why?
|
Oxygen | 3 | 2021 | 4189 | 0.150 |
Why?
|
Aged, 80 and over | 24 | 2022 | 57776 | 0.150 |
Why?
|
Hemodynamics | 12 | 2016 | 4196 | 0.150 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 442 | 0.150 |
Why?
|
Observer Variation | 5 | 2013 | 2593 | 0.150 |
Why?
|
Body Surface Potential Mapping | 1 | 2018 | 238 | 0.140 |
Why?
|
Electric Impedance | 1 | 2001 | 729 | 0.140 |
Why?
|
Mitral Valve Prolapse | 1 | 2018 | 231 | 0.140 |
Why?
|
HIV | 2 | 2023 | 1604 | 0.140 |
Why?
|
Chagas Cardiomyopathy | 1 | 2016 | 71 | 0.140 |
Why?
|
Aortic Coarctation | 2 | 2016 | 281 | 0.140 |
Why?
|
Adiponectin | 2 | 2019 | 1101 | 0.140 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2017 | 281 | 0.140 |
Why?
|
Pilot Projects | 9 | 2024 | 8319 | 0.130 |
Why?
|
Norwood Procedures | 1 | 2017 | 182 | 0.130 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2014 | 143 | 0.130 |
Why?
|
Vena Cava, Inferior | 1 | 2019 | 440 | 0.130 |
Why?
|
Diagnostic Imaging | 3 | 2012 | 3508 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2022 | 314 | 0.130 |
Why?
|
Carotid Artery, Common | 1 | 2016 | 183 | 0.130 |
Why?
|
Oxides | 1 | 1997 | 405 | 0.130 |
Why?
|
Disease Progression | 10 | 2019 | 13286 | 0.130 |
Why?
|
Chi-Square Distribution | 7 | 2017 | 3508 | 0.130 |
Why?
|
Computer Simulation | 5 | 2009 | 6194 | 0.130 |
Why?
|
Pentetic Acid | 6 | 1997 | 213 | 0.130 |
Why?
|
Pulmonary Circulation | 1 | 2017 | 739 | 0.130 |
Why?
|
Radiopharmaceuticals | 3 | 2020 | 2645 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2014 | 182 | 0.120 |
Why?
|
Monocytes | 2 | 2022 | 2596 | 0.120 |
Why?
|
Fish Oils | 1 | 2018 | 470 | 0.120 |
Why?
|
Body Fat Distribution | 1 | 2015 | 244 | 0.120 |
Why?
|
Lymphoma | 1 | 2023 | 1877 | 0.120 |
Why?
|
Fontan Procedure | 3 | 2019 | 776 | 0.120 |
Why?
|
Leptin | 2 | 2019 | 1600 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2022 | 2513 | 0.120 |
Why?
|
Abdominal Fat | 1 | 2015 | 223 | 0.120 |
Why?
|
Asymptomatic Diseases | 4 | 2019 | 551 | 0.120 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1997 | 476 | 0.120 |
Why?
|
Albuminuria | 2 | 2015 | 681 | 0.120 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12244 | 0.120 |
Why?
|
Random Allocation | 4 | 2013 | 2428 | 0.110 |
Why?
|
Organ Size | 6 | 2016 | 2251 | 0.110 |
Why?
|
Dogs | 9 | 2008 | 3912 | 0.110 |
Why?
|
Endocardium | 2 | 2011 | 263 | 0.110 |
Why?
|
Fibroblasts | 1 | 2023 | 4162 | 0.110 |
Why?
|
Porosity | 1 | 1994 | 362 | 0.110 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 818 | 0.110 |
Why?
|
Chest Pain | 1 | 2020 | 1114 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5749 | 0.110 |
Why?
|
United States | 18 | 2022 | 69872 | 0.110 |
Why?
|
Adolescent | 22 | 2020 | 85779 | 0.110 |
Why?
|
Heart Rate | 3 | 2019 | 4092 | 0.110 |
Why?
|
Proportional Hazards Models | 10 | 2017 | 12356 | 0.110 |
Why?
|
Triglycerides | 3 | 2016 | 2453 | 0.110 |
Why?
|
Papillary Muscles | 2 | 2018 | 203 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2008 | 591 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
Retrospective Studies | 19 | 2023 | 77460 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 361 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1403 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 517 | 0.100 |
Why?
|
Ferrosoferric Oxide | 2 | 2007 | 360 | 0.100 |
Why?
|
Cross-Sectional Studies | 14 | 2022 | 25039 | 0.100 |
Why?
|
Child | 17 | 2023 | 77709 | 0.100 |
Why?
|
Hypertrophy | 1 | 2013 | 569 | 0.100 |
Why?
|
Body Mass Index | 9 | 2016 | 12721 | 0.100 |
Why?
|
Cell Size | 1 | 2013 | 643 | 0.100 |
Why?
|
Phenotype | 7 | 2024 | 16367 | 0.100 |
Why?
|
Physical Fitness | 1 | 2016 | 732 | 0.100 |
Why?
|
Injections, Intravenous | 4 | 2018 | 1420 | 0.100 |
Why?
|
Vascular Resistance | 2 | 2015 | 936 | 0.100 |
Why?
|
Blood Pressure | 7 | 2020 | 8551 | 0.100 |
Why?
|
Sex Factors | 8 | 2017 | 10400 | 0.090 |
Why?
|
Feasibility Studies | 7 | 2014 | 5077 | 0.090 |
Why?
|
C-Reactive Protein | 4 | 2015 | 3778 | 0.090 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2013 | 272 | 0.090 |
Why?
|
Rheology | 2 | 2009 | 345 | 0.090 |
Why?
|
Registries | 4 | 2022 | 8091 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2016 | 1572 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2337 | 0.090 |
Why?
|
Child, Preschool | 13 | 2021 | 41005 | 0.090 |
Why?
|
Foundations | 1 | 2010 | 94 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2008 | 1873 | 0.090 |
Why?
|
Carotid Arteries | 1 | 2014 | 950 | 0.090 |
Why?
|
Phantoms, Imaging | 3 | 2022 | 2480 | 0.090 |
Why?
|
Mutation | 4 | 2017 | 29786 | 0.090 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2010 | 93 | 0.090 |
Why?
|
Analysis of Variance | 4 | 2013 | 6366 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1487 | 0.080 |
Why?
|
Spinal Canal | 1 | 2009 | 39 | 0.080 |
Why?
|
Tricuspid Valve | 2 | 2009 | 403 | 0.080 |
Why?
|
Smoking | 5 | 2012 | 8987 | 0.080 |
Why?
|
Diet, Mediterranean | 1 | 2015 | 700 | 0.080 |
Why?
|
Health Status Disparities | 2 | 2017 | 1796 | 0.080 |
Why?
|
England | 3 | 2017 | 522 | 0.080 |
Why?
|
Longitudinal Studies | 5 | 2017 | 13991 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2015 | 691 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 546 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2099 | 0.080 |
Why?
|
Incidence | 9 | 2017 | 20952 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 1421 | 0.080 |
Why?
|
Heart Function Tests | 1 | 2009 | 328 | 0.080 |
Why?
|
Neovascularization, Physiologic | 3 | 2006 | 1351 | 0.080 |
Why?
|
Double-Blind Method | 5 | 2023 | 12025 | 0.080 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2007 | 16 | 0.080 |
Why?
|
Aldosterone | 1 | 2013 | 877 | 0.080 |
Why?
|
Inflammation Mediators | 2 | 2014 | 1888 | 0.080 |
Why?
|
Mice | 5 | 2020 | 81201 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2010 | 525 | 0.080 |
Why?
|
Prevalence | 7 | 2022 | 15221 | 0.070 |
Why?
|
Radioisotopes | 1 | 2008 | 500 | 0.070 |
Why?
|
Pulsatile Flow | 1 | 2008 | 332 | 0.070 |
Why?
|
Vasodilation | 3 | 2007 | 944 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2014 | 854 | 0.070 |
Why?
|
Ligation | 2 | 2004 | 453 | 0.070 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1476 | 0.070 |
Why?
|
Area Under Curve | 3 | 2017 | 1655 | 0.070 |
Why?
|
Neoplasms | 2 | 2012 | 21696 | 0.070 |
Why?
|
ROC Curve | 4 | 2017 | 3528 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2016 | 1440 | 0.070 |
Why?
|
Rest | 3 | 2007 | 901 | 0.070 |
Why?
|
Inflammation | 3 | 2016 | 10637 | 0.070 |
Why?
|
Heterocyclic Compounds | 1 | 2007 | 249 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2010 | 374 | 0.070 |
Why?
|
Exercise | 2 | 2020 | 5615 | 0.070 |
Why?
|
Recovery of Function | 4 | 2019 | 2926 | 0.070 |
Why?
|
Retinal Diseases | 2 | 2012 | 684 | 0.070 |
Why?
|
Advisory Committees | 1 | 2010 | 775 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2016 | 5096 | 0.070 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 535 | 0.070 |
Why?
|
Myocardial Stunning | 1 | 2005 | 68 | 0.070 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 531 | 0.070 |
Why?
|
Laser Therapy | 2 | 2004 | 1072 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6539 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1018 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 944 | 0.070 |
Why?
|
Electrodes | 2 | 2014 | 619 | 0.070 |
Why?
|
Motion | 1 | 1989 | 798 | 0.070 |
Why?
|
Polylysine | 2 | 1996 | 133 | 0.060 |
Why?
|
Blood Glucose | 3 | 2016 | 6254 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2006 | 364 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2010 | 824 | 0.060 |
Why?
|
Liver | 2 | 2019 | 7475 | 0.060 |
Why?
|
Societies, Medical | 2 | 2022 | 3743 | 0.060 |
Why?
|
Coronary Restenosis | 1 | 2007 | 424 | 0.060 |
Why?
|
Constriction | 1 | 2004 | 181 | 0.060 |
Why?
|
Animal Experimentation | 1 | 2004 | 45 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2864 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 1005 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 408 | 0.060 |
Why?
|
Cohort Studies | 8 | 2017 | 40559 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2638 | 0.060 |
Why?
|
Absorbable Implants | 1 | 2006 | 342 | 0.060 |
Why?
|
Enalapril | 2 | 2017 | 327 | 0.060 |
Why?
|
Respiration | 3 | 2019 | 1653 | 0.060 |
Why?
|
Equipment Design | 4 | 2014 | 3582 | 0.060 |
Why?
|
Consensus | 2 | 2022 | 2960 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1184 | 0.060 |
Why?
|
Autopsy | 1 | 2007 | 1020 | 0.060 |
Why?
|
Leadership | 2 | 2022 | 1357 | 0.060 |
Why?
|
Tomography, Emission-Computed | 2 | 2012 | 1144 | 0.050 |
Why?
|
Fluoroscopy | 2 | 2004 | 924 | 0.050 |
Why?
|
Troponin T | 2 | 2018 | 754 | 0.050 |
Why?
|
Blood Volume | 4 | 1999 | 565 | 0.050 |
Why?
|
Waist Circumference | 2 | 2016 | 917 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12961 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3444 | 0.050 |
Why?
|
Subcutaneous Fat | 2 | 2015 | 391 | 0.050 |
Why?
|
Ventricular Function | 1 | 2004 | 415 | 0.050 |
Why?
|
Radiation Dosage | 1 | 2010 | 1928 | 0.050 |
Why?
|
Infant | 7 | 2019 | 35134 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2024 | 472 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2004 | 369 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 209 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2002 | 327 | 0.050 |
Why?
|
Renin | 1 | 2023 | 642 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1534 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2024 | 2016 | 0.050 |
Why?
|
Diabetes Complications | 2 | 2006 | 1359 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 294 | 0.050 |
Why?
|
Health Status | 1 | 2014 | 4034 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 383 | 0.050 |
Why?
|
Cryopreservation | 1 | 2005 | 670 | 0.050 |
Why?
|
Dilatation, Pathologic | 2 | 2015 | 520 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 1813 | 0.050 |
Why?
|
Graft Survival | 2 | 2016 | 3737 | 0.050 |
Why?
|
Anti-Retroviral Agents | 2 | 2020 | 1714 | 0.050 |
Why?
|
Troponin | 1 | 2004 | 524 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3255 | 0.050 |
Why?
|
Angina Pectoris | 2 | 2018 | 977 | 0.050 |
Why?
|
Logistic Models | 4 | 2016 | 13409 | 0.050 |
Why?
|
Lung Volume Measurements | 1 | 2001 | 378 | 0.040 |
Why?
|
Palliative Care | 2 | 2015 | 3493 | 0.040 |
Why?
|
Angina, Unstable | 2 | 2018 | 926 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3047 | 0.040 |
Why?
|
Proinsulin | 1 | 2019 | 133 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 478 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2024 | 582 | 0.040 |
Why?
|
Cholesterol, HDL | 2 | 2016 | 1813 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 670 | 0.040 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 868 | 0.040 |
Why?
|
Venous Pressure | 1 | 2019 | 56 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 21833 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 1 | 2003 | 793 | 0.040 |
Why?
|
Necrosis | 2 | 2017 | 1643 | 0.040 |
Why?
|
Cardiology | 1 | 2010 | 1668 | 0.040 |
Why?
|
Hepatic Veins | 1 | 2019 | 112 | 0.040 |
Why?
|
Prolapse | 1 | 2018 | 68 | 0.040 |
Why?
|
Chronic Disease | 4 | 2018 | 9145 | 0.040 |
Why?
|
Linoleic Acid | 1 | 2019 | 157 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2005 | 1431 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 784 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13693 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 434 | 0.040 |
Why?
|
C-Peptide | 1 | 2019 | 419 | 0.040 |
Why?
|
Bicycling | 1 | 2019 | 176 | 0.040 |
Why?
|
Recurrence | 3 | 2014 | 8340 | 0.040 |
Why?
|
Electromagnetic Fields | 1 | 1999 | 298 | 0.040 |
Why?
|
RNA, Small Untranslated | 1 | 2018 | 76 | 0.040 |
Why?
|
Calcinosis | 1 | 2006 | 1499 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 1585 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2013 | 6896 | 0.040 |
Why?
|
Germany | 1 | 2019 | 862 | 0.040 |
Why?
|
Biopsy | 3 | 2016 | 6755 | 0.040 |
Why?
|
Glucosides | 1 | 2021 | 451 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1681 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2002 | 1254 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4185 | 0.040 |
Why?
|
Echo-Planar Imaging | 1 | 2001 | 659 | 0.040 |
Why?
|
Mathematics | 1 | 1998 | 728 | 0.040 |
Why?
|
Posture | 1 | 2001 | 958 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5388 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2004 | 3589 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2184 | 0.030 |
Why?
|
Cholesterol | 1 | 2004 | 2919 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3309 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2016 | 216 | 0.030 |
Why?
|
Magnetite Nanoparticles | 1 | 1997 | 321 | 0.030 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2015 | 91 | 0.030 |
Why?
|
Dextrans | 1 | 1997 | 595 | 0.030 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2015 | 93 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.030 |
Why?
|
Dipyridamole | 2 | 2008 | 145 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2015 | 214 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 845 | 0.030 |
Why?
|
Principal Component Analysis | 2 | 2008 | 940 | 0.030 |
Why?
|
Capillaries | 1 | 1998 | 773 | 0.030 |
Why?
|
Simvastatin | 1 | 2017 | 360 | 0.030 |
Why?
|
Minnesota | 1 | 2015 | 344 | 0.030 |
Why?
|
Hydrochlorothiazide | 1 | 2014 | 98 | 0.030 |
Why?
|
Lung | 1 | 2012 | 9857 | 0.030 |
Why?
|
Survival Rate | 3 | 2014 | 12788 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1584 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5101 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 674 | 0.030 |
Why?
|
Body Weight | 2 | 2015 | 4671 | 0.030 |
Why?
|
Wound Healing | 1 | 2004 | 2785 | 0.030 |
Why?
|
Troponin I | 1 | 2017 | 619 | 0.030 |
Why?
|
Fourier Analysis | 2 | 1995 | 447 | 0.030 |
Why?
|
Heart Bypass, Right | 1 | 2013 | 74 | 0.030 |
Why?
|
Atrial Function | 1 | 2013 | 107 | 0.030 |
Why?
|
Adipokines | 1 | 2015 | 320 | 0.030 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 194 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2015 | 723 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 987 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2007 | 1590 | 0.030 |
Why?
|
Body Surface Area | 1 | 2012 | 199 | 0.030 |
Why?
|
Vena Cava, Superior | 1 | 2013 | 193 | 0.030 |
Why?
|
Odds Ratio | 2 | 2015 | 9849 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1739 | 0.030 |
Why?
|
Lysosomal Storage Diseases | 1 | 2012 | 79 | 0.030 |
Why?
|
Permeability | 1 | 1994 | 738 | 0.030 |
Why?
|
Comorbidity | 2 | 2017 | 10388 | 0.030 |
Why?
|
Diuretics | 1 | 2014 | 591 | 0.020 |
Why?
|
Magnetics | 2 | 2010 | 606 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1312 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 20824 | 0.020 |
Why?
|
Protein Precursors | 1 | 2015 | 1154 | 0.020 |
Why?
|
Hemoglobins | 1 | 2016 | 1532 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2017 | 17446 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 1475 | 0.020 |
Why?
|
Regression Analysis | 2 | 2011 | 6459 | 0.020 |
Why?
|
Spirometry | 1 | 2012 | 865 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6364 | 0.020 |
Why?
|
Lipids | 2 | 2014 | 3307 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1768 | 0.020 |
Why?
|
Thermodilution | 1 | 2009 | 52 | 0.020 |
Why?
|
Creatinine | 1 | 2015 | 1919 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 207 | 0.020 |
Why?
|
Oximetry | 1 | 2012 | 471 | 0.020 |
Why?
|
Primary Prevention | 1 | 2016 | 1167 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1781 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 535 | 0.020 |
Why?
|
Boston | 2 | 2011 | 9312 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7147 | 0.020 |
Why?
|
Brain | 1 | 1995 | 26388 | 0.020 |
Why?
|
Marfan Syndrome | 1 | 2010 | 240 | 0.020 |
Why?
|
Atrial Septum | 1 | 2008 | 60 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1516 | 0.020 |
Why?
|
Water | 1 | 1994 | 1395 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1904 | 0.020 |
Why?
|
Ultrasonography | 2 | 2016 | 5984 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2355 | 0.020 |
Why?
|
Body Height | 1 | 2012 | 1578 | 0.020 |
Why?
|
Sampling Studies | 1 | 2007 | 623 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8861 | 0.020 |
Why?
|
Radiography | 2 | 2009 | 7023 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4459 | 0.020 |
Why?
|
Computer Systems | 1 | 2006 | 483 | 0.020 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2010 | 546 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 1995 | 2732 | 0.020 |
Why?
|
Survivors | 1 | 2015 | 2291 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6489 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3338 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2004 | 683 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4397 | 0.010 |
Why?
|
Heart Septum | 1 | 2004 | 312 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1616 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2014 | 1519 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4424 | 0.010 |
Why?
|
Lung Diseases | 1 | 2012 | 1887 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1303 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3751 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3420 | 0.010 |
Why?
|
Fibrin | 1 | 2004 | 506 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2616 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2506 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1471 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2004 | 913 | 0.010 |
Why?
|
Mesoderm | 1 | 2004 | 686 | 0.010 |
Why?
|
Thallium Radioisotopes | 1 | 2001 | 139 | 0.010 |
Why?
|
Insulin | 1 | 2015 | 6582 | 0.010 |
Why?
|
Radionuclide Imaging | 2 | 1995 | 2031 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2003 | 493 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15520 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5660 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4216 | 0.010 |
Why?
|
Aortic Valve | 1 | 2009 | 1924 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2004 | 2124 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 2000 | 379 | 0.010 |
Why?
|
Myoglobin | 1 | 1999 | 160 | 0.010 |
Why?
|
Phosphocreatine | 1 | 1999 | 269 | 0.010 |
Why?
|
Health Care Costs | 1 | 2011 | 3208 | 0.010 |
Why?
|
Catheterization | 1 | 2003 | 1470 | 0.010 |
Why?
|
Drug Residues | 1 | 1996 | 7 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7184 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 2251 | 0.010 |
Why?
|
Models, Animal | 1 | 2003 | 2173 | 0.010 |
Why?
|
Dobutamine | 1 | 1996 | 123 | 0.010 |
Why?
|
Nanoparticles | 1 | 2007 | 1905 | 0.010 |
Why?
|
Stents | 1 | 2007 | 3282 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2003 | 1387 | 0.010 |
Why?
|
Phosphates | 1 | 1999 | 785 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9688 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1999 | 2027 | 0.010 |
Why?
|
Cell Movement | 1 | 2004 | 5218 | 0.010 |
Why?
|
Drug Combinations | 1 | 1997 | 1958 | 0.010 |
Why?
|
Specimen Handling | 1 | 1996 | 694 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 25628 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 3567 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 1997 | 1486 | 0.010 |
Why?
|
Stroke | 1 | 2011 | 9981 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2004 | 19233 | 0.010 |
Why?
|
Kinetics | 1 | 1995 | 6476 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2004 | 11486 | 0.000 |
Why?
|